Exclusive launch deal. Use code STONELAUNCH_2026 for $50 off all weight loss products each month for 6 months!

GLP-1 Weight Loss Plateau: Why It Happens and What to Do Next

Weight loss on a GLP-1 almost always slows down eventually. Here is why plateaus happen, how to tell if you have hit one, and what may help next.

7 min read

By Stone Health Editorial Team

Last updated

Weathered limestone garden steps leading to a wide, flat stone landing edged with sage-green grasses and small olive shrubs in soft early-morning light.

Key takeaways

  • A slowdown in weight loss after the first several months is expected on a GLP-1 medication. It usually means your body has adjusted, not that the medication has stopped working.
  • As you lose weight, your appetite tends to push back and your body burns somewhat less energy. Eventually intake and energy use meet at a new, lower weight.
  • Before deciding you have plateaued, look at the trend over several weeks, not day-to-day scale readings.
  • Practical levers include protein, strength training, sleep, alcohol, and consistent dosing. Some medications can also make weight loss harder.
  • A clinician can review your dose, your other medications, and whether your current weight may be a healthy place to maintain.

About the research in this article

The clinical trial results mentioned in this article come from studies of FDA-approved, brand-name medications: Wegovy (semaglutide) and Zepbound (tirzepatide). Compounded versions of semaglutide and tirzepatide are not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness, or quality before they are sold. Results from studies of FDA-approved products cannot be assumed to apply to compounded versions. The general guidance on plateaus below is about how the body responds to weight loss, not about any specific product.

What is a weight loss plateau?

A weight loss plateau is a stretch of weeks when your weight stays roughly the same even though you are following the same treatment plan. On a GLP-1 medication, it often shows up after a period of steady loss, and it can feel discouraging when the early pace was fast.

It helps to separate a true plateau from normal noise. Body weight can swing by a few pounds from one day to the next because of fluid, salt, constipation, hormones, and the timing of meals. A plateau is a flat trend over several weeks, not a few frustrating weigh-ins.

Why weight loss slows down on a GLP-1

Your appetite pushes back

The body defends against weight loss. A study by researchers including Kevin Hall of the National Institutes of Health estimated how much appetite rises as weight comes off. In people with type 2 diabetes taking a medication that causes calorie loss through the urine, food intake rose by roughly 100 calories a day for every kilogram (about 2.2 pounds) of weight lost. That push-back was several times larger than the drop in calories burned.

The study involved a different type of drug than GLP-1 medications, and all participants had diabetes, so the exact numbers may not apply to everyone. But it illustrates a general principle: the more weight you lose, the stronger the biological drive to eat. GLP-1 medications help counter that drive, but they do not erase it.

Your body needs less energy

A smaller body uses less energy, both at rest and during movement. Losing muscle along with fat can lower energy needs further. So the calorie gap that produced steady weight loss in the early months gets smaller over time.

Weight settles at a new level

Put those two forces together and weight loss naturally slows until it levels off at a new, lower weight, where the energy you take in and the energy you use are back in balance. The same NIH research team describes this as a common pattern across weight-loss approaches: initial loss, then a plateau. On a GLP-1, that new level is usually lower than you would reach without the medication, but it is still a level.

What the trials show about how much weight people lose

The prescribing information for Wegovy and Zepbound describes the large trials used for FDA approval. These studies lasted 68 to 72 weeks and included lifestyle counseling alongside the medication or placebo.

FDA-approved product and doseTrial lengthAverage weight changeLost at least 5% of body weight
Wegovy (semaglutide) 2.4 mg weekly68 weeks-14.9% (placebo: -2.4%)83.5% (placebo: 31.1%)
Wegovy (semaglutide) 7.2 mg weekly72 weeks-18.8% (placebo: -3.9%)88.7% (placebo: 38.3%)
Zepbound (tirzepatide) 5 mg weekly72 weeks-15.0% (placebo: -3.1%)85.1% (placebo: 34.5%)
Zepbound (tirzepatide) 15 mg weekly72 weeks-20.9% (placebo: -3.1%)90.9% (placebo: 34.5%)

Source: Wegovy and Zepbound prescribing information, adults with obesity or overweight without type 2 diabetes. Results apply only to the FDA-approved products studied.

Two points stand out. First, these are averages, and individual results varied widely. In the Wegovy 2.4 mg trial, about 1 in 6 people taking the medication lost less than 5% of their body weight. Second, the results were measured after more than a year of treatment. Weight loss is not a straight line, and a slower phase after the first several months is part of the usual course.

Is it a plateau, or something else?

Before changing anything, it is worth checking a few things:

  • Look at the trend. Weigh yourself at the same time of day under similar conditions, and compare weekly or monthly averages rather than single readings.
  • Consider other measures. Waist size, how clothes fit, strength, energy, blood pressure, and blood sugar can keep improving even when the scale is flat.
  • Check for short-term causes. Constipation, a salty meal, a menstrual cycle, a hard workout, or a recent illness can all temporarily hide progress.
  • Review your doses. Missed or late doses can blunt the effect of a weekly medication. The Wegovy label also advises restarting at a lower dose after two or more missed doses in a row, which can affect the pace of loss.

What may help you move past a plateau

Protect muscle with protein and strength training

A 2025 joint advisory from four U.S. nutrition and obesity organizations recommends a nutrient-dense eating pattern with adequate protein, strength training at least three times a week, and at least 150 minutes of moderate aerobic activity weekly for people on GLP-1 therapy. Keeping muscle helps maintain your energy needs and your strength. Our guide to preventing muscle loss on a GLP-1 covers protein targets and training in detail.

Revisit what and how you are eating

As appetite returns, portions and snacking can creep up without much notice. Liquid calories (sweetened coffee drinks, juice, and alcohol) are easy to overlook. A few days of writing down what you eat can reveal patterns. This is not about eating as little as possible: very low intake can worsen muscle loss and nutrient gaps.

Look at sleep, stress, and alcohol

Short sleep and high stress can make appetite harder to manage, and alcohol adds calories while lowering restraint around food. These are general clinical observations rather than findings specific to GLP-1 users, but they are reasonable areas to review.

Ask about other medications and health conditions

Some common medications are associated with weight gain, including certain antidepressants, antipsychotics, steroids, and diabetes medications such as insulin. Conditions such as an underactive thyroid can also play a role. Do not stop any medication on your own, but a clinician can review whether something on your list may be working against you. For women in midlife, hormonal changes can shift where and how weight is gained; see our article on menopause weight gain.

Talk with a clinician about your dose and goals

For the FDA-approved products, the labels describe dose ranges and say that treatment response and tolerability should guide the maintenance dose. Zepbound's maintenance options are 5 mg, 10 mg, or 15 mg weekly, and Wegovy's label allows an increase from 2.4 mg to as much as 7.2 mg weekly for some patients who tolerate the lower dose and need additional weight reduction. Whether a dose change makes sense depends on your side effects, health history, and goals. Higher doses can also mean more side effects; our guide to GLP-1 side effects explains what to watch for.

When a plateau may be your new normal

Sometimes a plateau is not a problem to solve. If your weight has stabilized at a level where your health markers have improved and you feel well, the goal may shift from losing more to maintaining what you have achieved. Maintenance is a real accomplishment, because the biological pressure to regain does not go away. If you are thinking about the long term, our article on what happens when you stop a GLP-1 explains why ongoing habits matter.

When to talk with a clinician

Reach out to your care team if:

  • Your weight has not changed for two or three months despite consistent treatment
  • You have lost very little weight since starting treatment
  • You are regaining weight while still on the medication
  • You are thinking about changing your dose, skipping doses, or stopping
  • You are eating very little, feel weak or lightheaded, or have side effects that make it hard to eat well

The bottom line

A GLP-1 weight loss plateau is usually a sign that your body has adapted to a lower weight, not that treatment has failed. Check the trend, protect your muscle, review habits and other medications, and talk with a clinician before changing your dose. If you have questions about a plateau or whether a GLP-1 medication may be right for you, Stone Health's clinicians can help. Learn more about our clinician-guided weight care or browse our frequently asked questions.

Frequently asked questions

Why did my weight loss stop on a GLP-1?
As you lose weight, appetite tends to rise and your body uses less energy. Over time these changes close the calorie gap, and weight levels off at a new, lower point. This is expected and does not necessarily mean the medication has stopped working.
How long does a GLP-1 plateau last?
It varies. Some plateaus are short pauses caused by fluid shifts or missed doses. Others reflect a new stable weight. If your weight has been flat for two to three months, talk with a clinician about whether any changes make sense.
Should I eat less to break a plateau?
Not necessarily. Eating very little can increase muscle loss and nutrient gaps. Focusing on protein, minimally processed foods, strength training, sleep and alcohol is usually a better first step than cutting calories further.
Does a plateau mean I need a higher dose?
Not always. A dose change depends on your side effects, health history and goals. A clinician can review whether your current dose, a different dose, or a focus on maintenance is the right next step.
Is it normal to stop losing weight on semaglutide or tirzepatide?
Yes. Weight loss on any treatment usually slows over time. Many people reach a point where weight stabilizes, and maintaining that lower weight is an important goal in itself.

This article is for educational purposes only and is not medical advice. It does not replace a consultation with a licensed clinician. Compounded medications are not FDA-approved. Talk to your clinician before starting, stopping, or changing any treatment. Read our editorial policy.